award

Dual action immunostimulatory nanoparticles for treatment of aggressive cancers

  • Award Number: R01CA278633

  • ORGANIZATION: NATIONAL CANCER INSTITUTE

  • OPDIV: NIH

  • AWARD CLASS: DISCRETIONARY

  • AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

  • PERIOD OF PERFORMANCE START DATE: 06/26/2023

  • PERIOD OF PERFORMANCE END DATE: 05/31/2025